POM121L2: A Potential Drug Target and Biomarker for Glycoprotein-Based Therapies

Target Name: POM121L2

NCBI ID: G94026

POM121L2

POM121L2: A Potential Drug Target and Biomarker for Glycoprotein-Based Therapies

Glycoproteins are a type of protein that consists of at least two polypeptide chains joined together. These chains are usually derived from different genes, and they can be expressed in various cell types. Glycoproteins play a crucial role in various physiological processes in the body, including cell signaling, tissue structure, and immune responses. They are also potential drug targets in the development of new therapies. In this article, we will discuss POM121L2, a glycoprotein that is of interest as a potential drug target and biomarker.

POM121L2 is a member of the POM family of glycoproteins. POM family proteins are involved in various cellular processes, including cell signaling, intracellular signaling, and tissue structure. The POM121L2 gene is located on chromosome 19q13.2 and encodes a 160-kDa protein that consists of two heavy chains and two light chains.

POM121L2 is expressed in various tissues and cell types, including the brain, heart, liver, and pancreas. It is also expressed in various cell lines, including HeK cells, a commonly used cell line for drug screening and screening of potential drugs. POM121L2 is a glycoprotein that is known for its unique structure and function.

One of the unique features of POM121L2 is its modular structure. POM121L2 consists of two heavy chains that are similar in sequence but differ in their N-terminus. The N-terminus of each heavy chain includes a unique domain that is specific to POM121L2. unique domain is known as the N-terminus domain, and it is responsible for the unique functions of POM121L2.

The N-terminus domain of POM121L2 is a 120-amino acid sequence that is specific to POM121L2. It is involved in the formation of the N-terminus region of the protein and is responsible for its unique structure and function. of POM121L2 has been shown to play a role in its stability and stability, as well as its function in various cellular processes.

Another unique feature of POM121L2 is its ability to interact with various signaling pathways. POM121L2 is involved in various signaling pathways, including the TGF-β pathway and the Wnt pathway. These signaling pathways are important for the development and maintenance of various tissues and organs, including the brain and heart.

POM121L2 is also involved in the regulation of cellular processes, including cell signaling and intracellular signaling. It is shown to play a role in the regulation of various cellular processes, including cell migration, cell adhesion, and cell signaling.

In addition to its role in cellular processes, POM121L2 is also of interest as a potential drug target. Its unique structure and function, as well as its involvement in various signaling pathways, make it an attractive target for new therapies.

POM121L2 can be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its expression is known to be increased in various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This makes it an attractive target for new therapies that can reduce the expression of POM121L2.

In addition to its potential as a drug target, POM121L2 is also of interest as a potential biomarker for various diseases. Its unique structure and function make it an attractive target for diagnostic tests, including protein arrays, Western blotting, and immunofluorescence. This makes POM121L2 an

Protein Name: POM121 Transmembrane Nucleoporin Like 2

The "POM121L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POM121L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets